Pharmacovigilance database. Good pharmacovigilance practices (GVP) are a set of measures drawn up...

Pharmacovigilance database. Good pharmacovigilance practices (GVP) are a set of measures drawn up to facilitate the performance of pharmacovigilance in the European Union (EU). Argus Safety Database is a software application developed by Oracle Corporation that is used for pharmacovigilance and drug safety management. This one-of-a-kind global resource supports the safer use of medicines and vaccines worldwide by helping members identify safety signals not visible from their data alone. They cover medicines authorised centrally via the Agency as well as medicines authorised at national level. It is designed to collect, manage, and analyze adverse event data from clinical trials, post-marketing surveillance, and spontaneous reports. The findings provide important evidence to support safe clinical use of mirtazapine and emphasize the need for continuous safety monitoring. The data sources (databases) may be owned by a pharmaceutical company, a drug regulatory authority, or a large healthcare provider. Strong working knowledge of ICH E2A/E2B (R3), EMA GVP, MedDRA coding, and safety databases (Oracle Argus, ARISg). The European Medicines Agency (EMA) is responsible for monitoring a number of substances and selected medical literature, to help identify suspected adverse reactions to medicines authorised in the European Union (EU). The intention of this tool is to expand access of FAERS Jun 14, 2025 · Top Pharmacovigilance Software Platforms Reviewed Oracle Argus Safety Oracle Argus Safety is the most widely used pharmacovigilance platform globally. Pharmacovigilance (PV) is a critical component of the global healthcare ecosystem, ensuring that medicines remain safe and effective after they are approved and introduced into the market. These databases play a vital role in the vigilance of the safety of medications and medical products after their approval and distribution. The FAERS Public Dashboard is a highly interactive web-based tool that will allow for the querying of FAERS data in a user friendly fashion. We offer specialised products, services, and expertise to support regulators and national authorities throughout the full range of their pharmacovigilance efforts, from data capture to management, analysis, and sharing. Collecting and analysing adverse Jun 6, 2024 · Pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other medicine-related problem. About VigiAccess VigiAccess was launched by the World Health Organization (WHO) in 2015 to provide public access to information in VigiBase, the WHO global database of reported potential side effects of medicinal products. In Singapore, pharmacovigilance activities are regulated by the Health Sciences Authority (HSA), which establishes strict regulatory requirements for Marketing Authorization Holders (MAHs) to monitor, detect 6 days ago · Strengthening safety surveillance UMC helps strengthen medicines and vaccine safety systems worldwide. Feb 20, 2026 · Objective: This study characterize adverse reactions associated with CYD-TDV and TAK-003 reported in the European pharmacovigilance database and to compare their post-marketing safety profiles. Apr 4, 2024 · Different pharmacovigilance (PV) systems and databases are used worldwide in the field of PV. Earn an accredited Pharmacovigilance Certification with CCRPS, focusing on drug safety, regulations, and best practices for healthcare professionals. Side effects – known technically as adverse drug reactions (ADRs) and adverse events following immunization (AEFIs) – are reported by national pharmacovigilance centres A pharmacovigilance safety database is the central repository for individual case safety reports, or ICSRs, collected for a company’s medicinal product (s) from all sources globally. Track record of improving case quality and cycle time Data mining pharmacovigilance databases is one approach that has become increasingly popular with the availability of extensive data sources and inexpensive computing resources. Dec 23, 2025 · What are the most commonly used drug safety databases? And, what do you need to consider when selecting a drug safety database. However, the quality of signal detection and of pharmacoepidemiology studies in the field of adverse drug reaction closely depends on the quality of the individual data recorded. . EMA also enters relevant information into the EudraVigilance database. Sep 18, 2019 · It is proposed that clozapine mortality may be further decreased by paying more attention to pneumonia, supported by an update of a review article and by the new data from a global database of adverse drug reactions (ADRs) for comparing the mortality associated with pneumonia and other clozAPine ADRs. GVP apply to marketing-authorisation holders, the European Medicines Agency (EMA) and medicines regulatory authorities in EU Member States. Pharmacovigilance (PV) is defined as the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem. The European Medicines Agency (EMA) coordinates the European Union (EU) pharmacovigilance system and operates services and processes to support pharmacovigilance in the EU. Although clozapine is underprescribed in many countries, it may be the most efficacious Professional Summary Pharmacovigilance Specialist with 5+ years of hands-on experience in case processing, signal detection, aggregate reporting and safety operations within mid-to-large pharmaceutical organizations. Methods: A retrospective pharmacovigilance study was conducted using the EudraVigilance database. 4 days ago · This study systematically assessed the long-term safety profile of mirtazapine using 21 years of real-world pharmacovigilance data from the FAERS database. It manages high-volume case processing, automated CIOMS and MedWatch generation, and multi-region submission tracking. This is because Feb 3, 2026 · VigiBase, the World Health Organization global database of adverse event reports for medicines and vaccines, holds over 40 million reports from 180+ WHO PIDM members (as of February 2025). With E2B (R3) support, real-time dashboards, and integration with Oracle’s clinical ecosystem, it’s optimized for Pharmacovigilance databases represent a considerable source of information. It is vital that any pharmacovigilance safety database is kept up to date with the latest regulatory requirements and validated to meet both international standards and business requirements. mvbibx enzyfx nwxqc tylrdzlu lpape egv ooinhk aby nzfp dali